Scam site is using our logo and reputation to run a scam! Please verify the authenticity of any site by checking it against the manufacturer’s official authorized sellers list.
We also do not sell products via Telegram (we use it strictly for announcements) or Whatsapp, Facebook or any other social media. Please remain vigilant against fraudulent Telegram channels, Whatsapp numbers, Facebook profiles.
Categories
Brands
Active Ingredient
Warehouses
Alfuzosin Information
Click here to view all Alfuzosin productsThe information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.
Alfuzosin is a medication that belongs to a class of drugs called alpha-1 blockers. It is primarily used to treat symptoms of an enlarged prostate gland, a condition known as benign prostatic hyperplasia (BPH).
Alfuzosin works by relaxing the muscles in the prostate gland and the bladder neck. This relaxation helps to relieve the symptoms associated with BPH, such as difficulty urinating, weak urine flow, frequent urination, and the need to urinate urgently or during the night.
By blocking the alpha-1 receptors in the smooth muscles of the prostate and bladder neck, Alfuzosin reduces the constriction of these muscles, allowing urine to flow more freely and relieving the pressure on the urethra. This results in improved urinary symptoms and increased urine flow.
Synonyms of Alfuzosin
- alfuzosin
- 81403-80-7
- Alfuzosina
- Alfuzosine
- Alfuzosinum
- Alfuzosine [French]
- Alfuzosinum [Latin]
- Alfusosine
- Alfuzosina [Spanish]
- Alfuzosin [INN:BAN]
- SL 77499
- ALFLUZOCIN
- ALFLUZOSIN
- alphuzosine
- Alfuzosin (INN)
- Xatral (TN)
- N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide
- HSDB 7290
- SL 77-499
- CHEMBL709
- NSC-760065
- UNII-90347YTW5F
- CHEBI:51141
- 90347YTW5F
- N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide
- N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide
- ALFUZOSIN [INN]
- 2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-
- SL 77
- N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide
- N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide
- 2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-
- SMR000466340
- N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)
- SR-01000759345
- Alfuzosin- Bio-X
- n-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide
- ALFUZOSIN [MI]
- ALFUZOSIN [HSDB]
- Prestwick0_000322
- Prestwick1_000322
- Prestwick2_000322
- Prestwick3_000322
- Spectrum2_000505
- Spectrum3_001063
- Spectrum4_001208
- Spectrum5_000817
- ALFUZOSIN [VANDF]
- D09MWJ
- ALFUZOSIN [WHO-DD]
- SCHEMBL34477
- BSPBio_000323
- BSPBio_002646
- KBioGR_001616
- MLS000759449
- MLS001424027
- MLS006011887
- SPECTRUM1505263
- SPBio_000429
- SPBio_002244
- BPBio1_000357
- GTPL7109
- DTXSID6048549
- KBio3_001866
- HMS1922P11
- HMS2051I10
- HMS2093O06
- HMS2235O22
- HMS3369K03
- HMS3393I10
- HMS3749I05
- HMS3886O22
- Pharmakon1600-01505263
- HY-B0192
- BDBM50033110
- CCG-39585
- MFCD00865792
- NSC760065
- s5766
- STK643675
- AKOS005574697
- CCG-100859
- DB00346
- NC00109
- NSC 760065
- SDCCGSBI-0206735.P002
- NCGC00095152-01
- NCGC00095152-02
- NCGC00095152-03
- NCGC00095152-04
- NCGC00095152-05
- NCGC00095152-07
- NCGC00095152-19
- BA164145
- LS-70106
- MS-26479
- SBI-0206735.P001
- AB00514667
- FT-0630891
- D07124
- F84998
- AB00514667-07
- AB00514667-09
- AB00514667-10
- AB00514667_11
- AB00514667_12
- (methyl)amino)propyl)tetrahydrofuran-2-carboxamide
- A840122
- EN300-19766666
- L001317
- Q2736873
- SR-01000759345-4
- BRD-A09056319-001-02-2
- BRD-A09056319-001-05-5
- BRD-A09056319-003-03-6
- N1-(4-amino-6,7-dimethoxyquinazol-2-yl)-N1-methyl-N2-(tetrahydrofuroyl-2)-propylenediamine
- (+/-)-N-(3-((4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)(METHYL)AMINO)PROPYL)TETRAHYDROFURAN-2-CARBOXAMIDE
- (+/-)-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide
- 1100050-87-0
- 2-FURANCARBOXAMIDE, (+/-)-N-(3-((4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)METHYLAMINO)PROPYL)TETRAHYDRO-
- N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide
- N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide;Alfuzosin
- N-{3-[(4-imino-6,7-dimethoxy-3,4-dihydroquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboximidic acid